If you’ve ever had a family member in a skilled nursing facility or stuck in post-op purgatory waiting for an IV team that’s “on the way,” you already know the punchline: mobile care in this country is too often a rolling joke with no delivery. Vellum Health just dropped a very different kind of punchline, and this one hits like truth serum.
On June 26, 2025, Vellum Health officially stepped out under a unified brand, backed by a fresh Series A round led by FCA Venture Partners with support from Green Park & Golf Ventures and follow-on angels like Michael Sanderson. The number? Not disclosed. But the message is loud: the future of post-acute IV care isn’t in the hospital wing, it’s rolling up to your bedside, wherever that may be. And at the wheel is Tyler Payne, Founder and CEO, who brings heavyweight credentials from CVS Health’s Clinical Trial Services and stints at Elligo Health Research and ePatientFinder. Molecular biology roots, MBA polish, and now he’s building something a lot more vital than another healthcare SaaS widget.
What Vellum Health is doing isn’t sexy until you realize it’s saving lives and healthcare dollars in the same breath. We’re talking mobile IV access (PIVs, midlines, PICCs), on-demand infusions for hydration, infection, cognition, and nutrition, plus bedside blood transfusions, all stitched together with a proprietary, AI-powered care coordination platform that knows which patients need what, when, and why. It’s a full-stack, cloud-native, HIPAA grade operation designed to treat the high-acuity, high-cost patients that traditional systems love to bounce around like a game of hot potato.
But here’s where it gets real: this isn’t some patchwork play. Vellum was built by consolidating acquired vascular access companies into a single operational engine, think less Frankenstein, more Formula One. The growth strategy? Scale state by state, deepen payer and hospital partnerships, and keep building that AI brain to know more, do more, faster. Every time Vellum shows up with a clinician instead of a costly ER transfer, that’s money saved, outcomes improved, and dignity restored.
So while others chase shiny objects and billion-dollar vaporware, Tyler Payne and team are moving with precision into one of the most overlooked, expensive, and fragmented parts of U.S. healthcare. The company is headquartered in Austin but their impact is spreading nationwide, bringing a value-based mindset to a broken model that’s overdue for overhaul.
And if the name Vellum sounds smooth, that’s because it is, thin, strong, and designed to carry something important. Just like the care they deliver.
This isn’t disruption for disruption’s sake. It’s reinforcement where the system’s buckling. And Vellum Health is showing up with real solutions, one vein at a time.
